On June 24, CDC’s Advisory Committee on Immunization Practices (ACIP) recommended that Moderna’s COVID-19 vaccine be used as an option for children ages 6 through 17 years, in addition to its already recommended use in children 6 months through 5 years and adults 18 years and older. This recommendation reinforces the use of Moderna’s COVID-19 vaccine as an important tool in the pandemic and provides another vaccine option for children and adolescents. The ACIP recommendation comes after a thorough review of the scientific evidence demonstrating safety and efficacy and supports the use of the vaccine among those 6 through 17 years of age. For more information, explore the CDC’s COVID-19 Vaccine Recommendations for Children and Teens webpage.
